Alan Philips

Dr Alan Philips

Back to top

Biography

Alan Phillips is a highly respected seasoned professional providing biostatistical consultancy and regulatory advice services to the Pharmaceutical and CRO industry.

After graduating from the universities of Exeter and Birmingham in 1982 and 1987 respectively, Dr Phillips has spent 40 years working in the Pharmaceutical and CRO industry, both in Europe and the US. During this period, he has gained extensive knowledge of clinical trials, statistical methodology and world-wide statistical regulatory requirements.

Dr Phillips has experience of providing Biostatistical input into clinical development plans in a wide range of Therapeutic Areas, including individual clinical trial design support (estimand development, statistical analysis strategy and sample size), and preparation of Biostatistical regulatory questions and attendance at FDA and EMA Scientific Advice meetings. Dr Phillips also has extensive experience of Data Monitoring Committees membership.

Furthermore, Dr Phillips was appointment an honorary member of “Statisticians in the Pharmaceutical Industry" in 2015...

more

Journal Articles

  • Phillips, A. and Mondal, S., 2023. Improving early phase oncology clinical trial design: The case for finding the optimal biological dose. Pharmaceutical Statistics, 22 (4), 739-747.
  • Phillips, A. and Mondal, S., 2023. Improving early phase oncology clinical trial design: An opportunity for statisticians. Pharmaceutical Statistics, 22 (3), 577-580.
  • Phillips, A.J. and Clark, T.P., 2022. Improving early phase oncology clinical trial design: A case study. Pharmaceutical Statistics, 21 (6), 1370-1375.
  • Phillips, A. and Clark, T., 2021. Estimands in practice: Bridging the gap between study objectives and statistical analysis. Pharmaceutical Statistics, 20 (1), 68-76.